Following the launch of its brand in Lithuania back in October 2018, Optibet has strengthened its current offering by including the addition of betting to its product range.
The news comes as the operator confirms the enhancement to its in-house development strategy, which seeks to create opportunities for customer acquisition, increased revenue, improved profit margin and a generally more diversified revenue model.
Robert Andersson, President and CEO, said of the launch: “This is a key launch for the entire Enlabs. Of course, that we offer betting in Lithuania means a lot to our business in this country, but it is also another big step towards being the obvious choice as an operator in “The Baltics and beyond”.
“It demonstrates the strength we have throughout the organisation, but above all it proves our technical expertise when we now launch a newly developed betting product on our new dynamic platform. This means that the new platform will become an even more competitive product, which in the long run will lead to significant efficiency gains throughout the organisation.”
As it stands, there are currently seven online licensed operators in Lithuania, with one of the main conditions meaning that all gaming operators must be tethered to land-based operations. As a result of this regulation, Enlabs currently operates 21 betting shops in the country, all under the Optibet brand.
“The launch of our own developed betting product is a very important milestone for Optibet in Lithuania, the largest of the Baltic states by population. Lithuania is the market where we see the greatest growth potential in the whole region. The fact that we can now deliver a broader product portfolio gives us great opportunities to accelerate our growth. We have clear indications of high demand for betting in Lithuania which makes me optimistic about the future. It has been a brilliant effort by the team and with the product out on market we will continue to offer Lithuania’s best customer service,” said Miko Salo, Chief Commercial Officer of Enlabs.